Latest Air Methods Corp (AIRM) Headlines Insider Trading

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Air Methods Corp (AIRM) Headlines

Insider Trading Alert - AIRM, CLB And CSGP Traded By Insiders
at The Street - Tue Mar 11, 12:30PM CDT
Stocks with insider trader activity include AIRM, CLB and CSGP

Financial Results, FDA Reviews, and Share Price Movements - Analyst Notes on Insys, Oxygen Biotherapeutics, Acorda, Air Methods, and AcelRx
PR Newswire - Fri Mar 07, 7:00AM CST
Today, Analysts Review released its analysts' notes regarding INSYS Therapeutics, Inc. (NASDAQ: INSY), Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), Acorda Therapeutics, Inc. (NASDAQ: ACOR), Air Methods Corp. (NASDAQ: AIRM), and AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Stocks End Higher; MercadoLibre Jumps After Hours
at Investor's Business Daily - Thu Feb 27, 3:58PM CST
Major averages closed higher Thursday after Federal Reserve chair Janet Yellen said bad weather may be behind recent weak economic data. The Nasdaq climbed 0.6%, while the Dow Jones industrial average and the S&P 500 added 0.5% each. But volume was...

Air Methods Reports Year 2013 Results and 1Q2014 Update
GlobeNewswire - Thu Feb 27, 3:14PM CST
Air Methods Corporation (Nasdaq:AIRM), the global leader in air medical transportation, reported financial results for the year and fourth quarter ended December 31, 2013.

Commit To Buy Air Methods Corp. At $40, Earn 6.8% Annualized Using Options
at The Street - Tue Feb 25, 10:39AM CST
Investors eyeing a purchase of Air Methods Corp. stock, but tentative about paying the going market price of $52.86/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Air Methods to Report Fourth Quarter and Fiscal Year 2013 Financial Results on Thursday, February 27, 2014
GlobeNewswire - Fri Feb 21, 10:30AM CST
Air Methods Corporation (Nasdaq:AIRM) will report financial results for the fourth quarter ended December 31, 2013 after the close of the market on Thursday, February 27, 2014. The Company has scheduled a conference call for Thursday, February 27, 2014 at 4:15 p.m. Eastern to discuss these results.

Air Methods Awarded Multiple International Completion Contracts
GlobeNewswire - Thu Feb 20, 3:01PM CST
Air Methods Corporation (Nasdaq:AIRM), the global leader in air medical transportation, announced today that its United Rotorcraft Division has been awarded contracts totaling up to $5.5 million with the Ecuadorian Navy, AgustaWestland, and an unnamed customer in the Middle East to design, manufacture, certify and complete several airframes for a variety of missions.

10-Q: BCSB BANCORP INC.
Edgar Online - Fri Feb 14, 7:57AM CST
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

This Healthcare Transportation Provider Is Really Going Places
John Leonard, The Motley Fool - Motley Fool - Tue Feb 11, 5:30PM CST
Providence Service , a provider of human social services and community transportation, is undervalued with an EBITDA -- earnings before interest, taxes, depreciation, and amortization -- multiple of only 6.8 due to uncertainty regarding the bidding...

Healthways Up on Healthcare Deal Extension - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 5:40PM CST
Healthways Up on the partnership deal extension with Essence Healthcare Deal Extension

Why Air Methods Shares Dipped and Rebounded Today
Mark Reeth and Brendan Mathews, The Motley Fool - Motley Fool - Wed Jan 29, 2:19PM CST
Shares of the helicopter-based ambulance service Air Methods dipped this morning after the company pre-announced earnings late yesterday, with the numbers coming in weaker than expected. The company blamed the poor quarter on a number of factors,...

Air Methods (AIRM) is now in Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 6:41AM CST
Air Methods (AIRM) is now in Oversold Territory

Air Methods Provides Update on 4th Quarter Results
GlobeNewswire - Tue Jan 28, 3:01PM CST
Profitability Affected by Weaker Flight Volumes and Slight Deterioration in Payer Mix

MedAssets Up on Contract Renewal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 6:30PM CST
MedAssets announces to renew multi -year agreement with Kaiser Permanente

Uptrend Call Working As Air Methods Stock Rises 37.4% (AIRM)
Comtex SmarTrend(R) - Wed Jan 22, 11:06AM CST
SmarTrend identified an Uptrend for Air Methods (NASDAQ:AIRM) on August 9th, 2013 at $39.56. In approximately 6 months, Air Methods has returned 37.38% as of today's recent price of $54.34.

Healthways Up on New Healthcare Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 6:20PM CST
Healthways enters into agreement with UCLA Health System

Sirocco and Canada Lithium Announce New Proposed Name for Canada Lithium
Marketwire - Tue Jan 21, 6:27AM CST
Sirocco Mining Inc. ("Sirocco") (TSX: SIM) and Canada Lithium Corp. ("Canada Lithium") (TSX: CLQ)(OTCQX: CLQMF) jointly announce that the new proposed name for Canada Lithium upon completion of the arrangement transaction between Sirocco and Canada Lithium (the "Arrangement") will be RB Energy Inc. (including a French form of such name, Energie RB Inc.").

Healthways Up on Carondelet Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 17, 4:13PM CST
Healthways signs deal with Carondelet Health Network of Southern Arizona

Shares of AIRM Up 39.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 15, 9:46AM CST
SmarTrend identified an Uptrend for Air Methods (NASDAQ:AIRM) on August 9th, 2013 at $39.56. In approximately 5 months, Air Methods has returned 39.86% as of today's recent price of $55.32.

Downgrade Alert for Air Methods (AIRM)
Comtex SmarTrend(R) - Wed Jan 15, 6:57AM CST
Air Methods (NASDAQ:AIRM) was downgraded from Strong Buy to Buy at Feltl today. The stock closed yesterday at $55.07 on volume of 282,000 shares, below average daily volume of 332,000. In the past 52 weeks, Air Methods share prices have been bracketed by a low of $32.24 and a high of $59.07 and closed yesterday at $55.07, 71% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 1.2%.

Air Methods Corp. (AIRM) Stock Research Links

AIRM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading